关键的临床前肿瘤学平台扩大,包括了新的患者源性的类器官模型

Ads

You May Also Like

Nkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of Growth

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held ...

Aeglea BioTherapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results

AUSTIN, Texas, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc., (NASDAQ:AGLE) a biotechnology ...